MAOPIN

This brand name is authorized in Nigeria.

Active ingredients

The drug MAOPIN contains one active pharmaceutical ingredient (API):

1	Carbamazepine UNII 33CM23913M - CARBAMAZEPINE
	Carbamazepine is a derivative of dibenzazepine. It belongs to the pharmaceutical class of antiepileptic, neurotropic and psychotropic drugs. Carbamazepine helps control the transmission of messages from the brain to the muscles.
	Read more about Carbamazepine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-9213	Tablet	MAOPIN TABLETS TAB 200 mg 1 X 1000	58 CMS-PP-248893 MAOPIN TABLETS 200MG CARBAMAZEPINE BP 200MG ACTIVE: Carbamazepine BP 200mg LIST OF EXCIPIENTS Microcrystalline cellulose, Sodium Starch Glycolate (Type A), Sodium Lauryl sulphate, Povidone (K-30), Magnesium Stearate A4-9213 Drugs Imported Products 11000 Prescription Only Medicine (POM) 1/28/2022 PHARMEXCO PHARMACEUTICALS LIMITED, 43, PRINCE FADINA STREET, OLODI LAGOS LAGOS 8186752515 stamexco@gmail.com CE-CHEM PHARMACEUTICALS PVT. LTD, No 336, IV PHASE, 9TH CROSS, PEENYA INDUSTRIAL AREA, BANGALORE-560 058, INDIA, India	27/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N03AF01	Carbamazepine	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AF Carboxamide derivatives
Discover more medicines within N03AF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-9213